Showing 661 - 680 results of 129,672 for search '(( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( i e decrease ))', query time: 1.91s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665

    Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

    Published 2013
    “…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”
  6. 666

    Decrease in extracellular Zn<sup>2+</sup> in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

    Published 2013
    “…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671

    GFP activity is decreased in DES. by Céline Portal (3876436)

    Published 2017
    “…<p><b>(a)</b> Scatterplots show that CGC number determined on histological sections (AB—PAS coloration), and GFP<sup>+</sup> (Muc5b) and Muc5ac<sup>+</sup> CGC number determined by immunofluorescence staining (anti-GFP and anti-Muc5ac antibody) decreased (n = 10 mice, 1 section per mouse, one symbol/mouse) after 10 days of BAK application (filled-in symbols) in one eye (PBS in the other, white-filled symbols) followed by 4 days without any treatment. …”
  12. 672
  13. 673
  14. 674
  15. 675

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  16. 676
  17. 677

    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

    Published 2021
    “…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10<sup>4</sup>) were plated in Transwell<sup>®</sup> inserts and allowed to invade for 1 week through a Matrigel<sup>™</sup> layer. …”
  18. 678
  19. 679
  20. 680